Clinical Trial

GLycaemic Outcomes With Whey Protein in ageING

Study acronym: GLOWING
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this placebo-controlled, partial crossover design study is to identify the impact of consuming whey protein before meals on free-living glucose control in older adults living with type 2 diabetes. The primary specific objective is to determine the effect of a thrice daily whey protein pre-meal supplementation at two doses, on glucose excursions over a 7-day free-living period in adults aged 75-90 years of age, living with type 2 diabetes, compared with a non-protein placebo. Participants will consume the whey protein and placebo for 7 days each, before each meal. All participants will consume the placebo and one of two doses of whey protein, in a randomised order.
Trial Details
NCT Number NCT07285811
Lead Sponsor University of Birmingham
Collaborators: Newcastle University
Conditions Type 2 Diabetes
Enrollment 32 participants
Start Date 2025-12
Primary Completion 2026-08 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-16